Format

Send to

Choose Destination
JAMA Oncol. 2015 Aug;1(5):577-9. doi: 10.1001/jamaoncol.2015.1457.

Has the Time Arrived for Biomarker-Directed Therapy in Castration-Resistant Prostate Cancer?

Author information

1
Lank Center of Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
2
Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts3Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
PMID:
26181796
DOI:
10.1001/jamaoncol.2015.1457
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center